OTHER INFORMATION
−Removed: Jane Emerson, notified the Board that she is stepping down as a member
−Removed: of the Board, effective November 1, 2025.
−Removed: Dr, Emerson’s resignation did not result from any disagreement with the Company on any
−Removed: matter relating to the Company’s operations, policies, or practices.
following exhibits are filed or furnished as part of this quarterly report on Form 10-Q:
−Removed: Certificate of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act
−Removed: Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act
−Removed: Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
−Removed: Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act
+Added: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Zackary S.
+Added: Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Gary Lu
+Added: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Zackary S.
+Added: Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Gary Lu
Interactive data files pursuant to Rule 405 Regulation S-T, as follows:
10 unchanged sentences
the undersigned thereunto duly authorized.
−Removed: Executive Officer
−Removed: Executive Officer)
−Removed: Financial Officer
−Removed: Financial Officer)
+Added: BIOMERICA, INC.
+Added: January 14, 2026
+Added: Chief Executive Officer
+Added: (Principal Executive Officer)
+Added: January 14, 2026
+Added: Chief Financial Officer
+Added: (Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.